Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0286 per EA under NDC 70010020303. Its NADAC has been published 156 times since Jul 5, 2023.
Strength
25 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010020303
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078403On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 156 times since Jul 5, 2023, and over the history we have for it it has declined 31.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0286 per EA |
|---|---|
| All-time high | $0.0417 (Jul 12, 2023) |
| All-time low | $0.0285 (Nov 20, 2024) |
| 52-week high | $0.0336 |
| 52-week low | $0.0286 |
| Median price | $0.0326 |
| Average price | $0.0335 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0286 per EA (NDC 70010020303), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 31.4%. It has been tracked across 156 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since Jul 5, 2023, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.0417 (Jul 12, 2023), with a median of $0.0326 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SERTRALINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 70010020303) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification